Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells

Oncogene
Christophe HéliezAnnie Valette

Abstract

CKI p21 is a regulator of cellular responses to microtubule damage induced by drugs such as paclitaxel (PTX). It mediates the G1 4N arrest postactivation of the spindle assembly checkpoint and protects cancer cells against PTX-induced cytotoxicity. We demonstrated here that low doses of PTX that are unable to activate the spindle assembly checkpoint, upregulate p21 by a p53-dependent pathway and induce its translocation to the cytoplasm. This cytoplasmic accumulation of p21 resulted from an AKT-dependent p21 phosphorylation leading to an association of p21 with 14-3-3. Furthermore, the cytoplasmic p21 accumulation observed in PTX-treated cells was inhibited by LY 294002, a specific PI-3 kinase inhibitor or by the expression of a dominant-negative AKT mutant. However, the kinase activity of AKT was unchanged in PTX-treated cells, suggesting that low doses of PTX could regulate p21 phosphorylation via inhibition of its dephosphorylation. As a functional consequence, we found that cytoplasmic accumulation of the phosphorylated form of p21 prevents the inhibitory effect of p21, enabling these cells to escape to the p53-dependent Gl/S and G2/M checkpoints.

References

May 15, 1995·Genes & Development·C J Sherr, J M Roberts
Mar 6, 1996·Journal of the National Cancer Institute·M M HawkinsM A Stovall
Jan 1, 1996·Stem Cells·J R BertinoD Banerjee
May 22, 2001·Molecular Biology of the Cell·P R AndreassenR L Margolis
Sep 5, 2001·Molecular and Cellular Biology·O ZugastiU Hibner
Jul 3, 2002·The Journal of Clinical Investigation·April L BlajeskiScott H Kaufmann
Mar 18, 2003·Molecular and Cellular Biology·Sonsoles ShackNikki J Holbrook

❮ Previous
Next ❯

Citations

Sep 15, 2006·Cancer Chemotherapy and Pharmacology·D HenleyJ Wimalasena
Oct 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Angela M Taylor, Coleen A McNamara
Dec 1, 2004·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Eun-Kyoung YimJong-Sup Park
Mar 1, 2007·Expert Opinion on Drug Discovery·Nadine DarwicheHala Gali-Muhtasib
May 27, 2006·Seminars in Cancer Biology·Guri TzivionVitaly Balan
Jan 25, 2006·International Journal of Cancer. Journal International Du Cancer·Carlos María GalmariniAlain Puisieux
Dec 28, 2006·The Journal of Biological Chemistry·Ayesha N ShajahanRobert Clarke
Oct 12, 2018·Cancers·Arnatchai MaiuthedRegine Schneider-Stock
Apr 3, 2020·International Journal of Oncology·Alice ZamagniChiara Molinari
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nichole Boyer ArnoldMurray Korc
Apr 27, 2005·The Journal of Biological Chemistry·Stephen E MercerEileen Friedman
Mar 15, 2021·European Journal of Medicinal Chemistry·Piyush GediyaManjunath D Ghate
Jul 7, 2021·Cell Death Discovery·Elena V SazonovaBoris Zhivotovsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.